|
Name |
(1S,4S,5S,7R,8S,12R)-5,12-dihydroxy-4-methyl-7-prop-1-en-2-yl-3,14-dioxatetracyclo[10.2.1.02,10.04,8]pentadec-2(10)-en-11-one
|
| Molecular Formula | C17H22O5 | |
| IUPAC Name* |
(1S,4S,5S,7R,8S,12R)-5,12-dihydroxy-4-methyl-7-prop-1-en-2-yl-3,14-dioxatetracyclo[10.2.1.02,10.04,8]pentadec-2(10)-en-11-one
|
|
| SMILES |
CC(=C)[C@@H]1C[C@@H]([C@@]2([C@H]1CC3=C(O2)[C@@H]4C[C@](C3=O)(CO4)O)C)O
|
|
| InChI |
InChI=1S/C17H22O5/c1-8(2)9-5-13(18)16(3)11(9)4-10-14(22-16)12-6-17(20,7-21-12)15(10)19/h9,11-13,18,20H,1,4-7H2,2-3H3/t9-,11-,12-,13-,16-,17+/m0/s1
|
|
| InChIKey |
IGDRQSDOUVIHQM-VMEHZNMRSA-N
|
|
| Synonyms |
CHEMBL3754388
|
|
| CAS | NA | |
| PubChem CID | 127035630 | |
| ChEMBL ID | CHEMBL3754388 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 306.4 | ALogp: | 0.6 |
| HBD: | 2 | HBA: | 5 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 76.0 | Aromatic Rings: | 4 |
| Heavy Atoms: | 22 | QED Weighted: | 0.719 |
| Caco-2 Permeability: | -4.916 | MDCK Permeability: | 0.00001350 |
| Pgp-inhibitor: | 0.018 | Pgp-substrate: | 0.846 |
| Human Intestinal Absorption (HIA): | 0.017 | 20% Bioavailability (F20%): | 0.009 |
| 30% Bioavailability (F30%): | 0.119 |
| Blood-Brain-Barrier Penetration (BBB): | 0.875 | Plasma Protein Binding (PPB): | 58.74% |
| Volume Distribution (VD): | 1.193 | Fu: | 47.62% |
| CYP1A2-inhibitor: | 0.023 | CYP1A2-substrate: | 0.533 |
| CYP2C19-inhibitor: | 0.023 | CYP2C19-substrate: | 0.788 |
| CYP2C9-inhibitor: | 0.009 | CYP2C9-substrate: | 0.031 |
| CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.084 |
| CYP3A4-inhibitor: | 0.025 | CYP3A4-substrate: | 0.484 |
| Clearance (CL): | 5.622 | Half-life (T1/2): | 0.272 |
| hERG Blockers: | 0.219 | Human Hepatotoxicity (H-HT): | 0.905 |
| Drug-inuced Liver Injury (DILI): | 0.657 | AMES Toxicity: | 0.35 |
| Rat Oral Acute Toxicity: | 0.819 | Maximum Recommended Daily Dose: | 0.827 |
| Skin Sensitization: | 0.372 | Carcinogencity: | 0.763 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.026 |
| Respiratory Toxicity: | 0.891 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002719 | ![]() |
0.686 | D0P0HT | ![]() |
0.257 | ||
| ENC003338 | ![]() |
0.635 | D03HYX | ![]() |
0.239 | ||
| ENC006127 | ![]() |
0.595 | D03BLF | ![]() |
0.239 | ||
| ENC006129 | ![]() |
0.564 | D0IT2G | ![]() |
0.239 | ||
| ENC003341 | ![]() |
0.554 | D0FL5V | ![]() |
0.239 | ||
| ENC002720 | ![]() |
0.538 | D07DVK | ![]() |
0.239 | ||
| ENC003657 | ![]() |
0.538 | D0CW1P | ![]() |
0.239 | ||
| ENC002721 | ![]() |
0.532 | D0V9DZ | ![]() |
0.231 | ||
| ENC006126 | ![]() |
0.506 | D0CZ1Q | ![]() |
0.231 | ||
| ENC003344 | ![]() |
0.469 | D08PIQ | ![]() |
0.231 | ||